Joshua Schultz is Senior Vice President & Worldwide Head of PAREXEL Access. Mr. Schultz is responsible for leadership and oversight of all late-stage clinical research, access consulting, drug safety and medical communications activities at PAREXEL. Since joining PAREXEL in 2005, Mr. Schultz has held a number of roles including the Head of the Strategic Partnership group, which focused on developing and executing innovative relationships with key pharmaceutical companies. Mr. Schultz was responsible for building an organization dedicated to efficient operational design and launch of clinical studies and another that focused on pharmacovigilance. Joshua Schultz is Senior Vice President & Worldwide Head of PAREXEL Access. Mr. Schultz is responsible for leadership and oversight of all late-stage clinical research, access consulting, drug safety and medical communications activities at PAREXEL. Since joining PAREXEL in 2005, Mr. Schultz has held a number of roles including the Head of the Strategic Partnership group, which focused on developing and executing innovative relationships with key pharmaceutical companies. Mr. Schultz was responsible for building an organization dedicated to efficient operational design and launch of clinical studies and another that focused on pharmacovigilance.

Joshua Schultz is expertise in Management Consulting, clinical research, access consulting.